# Biotech Daily Digest â€” 2025-11-19

**46 items from 5 sources**

## Summary by Source

- Eli Lilly Press Releases: 2 items
- Endpoints News: 6 items
- Fierce Biotech: 11 items
- Regeneron Press Releases: 1 item
- arXiv q-bio: 26 items


## Eli Lilly Press Releases

- **[Lilly announces plans to open Lilly Gateway Labs site in Philadelphia](https://investor.lilly.com/news-releases/news-release-details/lilly-announces-plans-open-lilly-gateway-labs-site-philadelphia)**  
  _Wed, 19 Nov 2025 06:45:00 -0500_  
  Gateway Labs model provides lab space and tailored scientific engagement to fuel next-generation medicines New Center City site, in partnership with Breakthrough Properties , will host a select group of early-stage biotech companies INDIANAPOLIS , Nov.

- **[Lilly to participate in Citi's 2025 Global Healthcare Conference](https://investor.lilly.com/news-releases/news-release-details/lilly-participate-citis-2025-global-healthcare-conference)**  
  _Tue, 18 Nov 2025 10:00:00 -0500_  
  INDIANAPOLIS , Nov. 18, 2025 /PRNewswire/ --Â Eli Lilly and Company (NYSE:LLY) will participate in the Citi's 2025 Global Healthcare Conference on December 2, 2025 . Ilya Yuffa , executive vice president and president Lilly USA and Global Customer Capabilities, will take part in a fireside chat at


## Endpoints News

- **[GSK picks LTZ Therapeutics in myeloid cell engager pact worth $50M upfront](https://endpoints.news/gsk-picks-ltz-therapeutics-in-myeloid-cell-engager-pact-worth-50m-upfront/)**  
  _Wed, 19 Nov 2025 11:58:05 +0000_  
  GSK will pay LTZ Therapeutics $50 million upfront for access to its myeloid cell engager (MCE) technology.

 The deal follows similar moves by Eli Lilly, Sanofi, Novartis and Pfizer aimed at developing entrants in this ...

- **[Nabla Bio announces AI antibody model update in JAM-2](https://endpoints.news/nabla-bio-announces-ai-antibody-model-update-in-jam-2/)**  
  _Wed, 19 Nov 2025 10:00:53 +0000_  
  The newest version of Nabla Bio's flagship AI model is creating antibodies that look more and more like possible drugs and is showing early hints at how the work might shave sizeable chunks off R ...

- **[Senator questions Lilly CEO on details of Trump deal for weight loss drugs](https://endpoints.news/senator-questions-lilly-ceo-on-details-of-trump-deal-for-weight-loss-drugs/)**  
  _Tue, 18 Nov 2025 20:16:32 +0000_  
  In a letter on Tuesday to Eli Lilly CEO David Ricks, Sen. Ruben Gallego (D-AZ) said the company needs to explain the details of its deal with the Trump administration over its weight loss drugs ...

- **[Makary calls for 'America First' drug user fee renegotiations](https://endpoints.news/makary-calls-for-america-first-drug-user-fee-renegotiations/)**  
  _Tue, 18 Nov 2025 19:14:27 +0000_  
  FDA Commissioner Marty Makary is embracing the Trump administration's "America First" mantra, seeking potentially higher user fees for companies operating outside the US.

 "If your Phase 1 trial is not in the United States, maybe ...

- **[SixPeaks CEO talks about $170M sale to AstraZeneca and what comes next in obesity](https://endpoints.news/sixpeaks-ceo-talks-about-170m-sale-to-astrazeneca-and-what-comes-next-in-obesity/)**  
  _Tue, 18 Nov 2025 15:47:23 +0000_  
  Metsera wasn't the only obesity company that was acquired this month.

 Tucked into AstraZeneca's third-quarter earnings update was the news that it bought Swiss-based SixPeaks Bio, which is working on drugs that ...

- **[Merck, Bristol Myers disclose layoffs in New Jersey](https://endpoints.news/merck-bristol-myers-disclose-layoffs-in-new-jersey/)**  
  _Tue, 18 Nov 2025 15:12:17 +0000_  
  Plus, news about Merck's Winrevair, Biokin, TC BioPharm, Nuvalent and Invivyd:

 ðŸ“‰ Layoffs at Merck in New Jersey: The drugmaker will let go of 204 workers in Rahway, NJ, effective in the months of ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/pharma/teva-calls-startups-rise-occasion-new-open-innovation-platform-targeting-7-biopharma" hreflang="en">Teva calls on startups to Rise to the occasion with open innovation platform for 7 biopharma challenges</a>](https://www.fiercebiotech.com/pharma/teva-calls-startups-rise-occasion-new-open-innovation-platform-targeting-7-biopharma)**  
  _Nov 18, 2025 4:15pm_  
  Teva Pharmaceutical is launching its first global innovation platform, challenging startups to submit novel strategies to tackle seven industry hurdles that run the gamut from manufacturing to R&D.

- **[<a href="https://www.fiercebiotech.com/biotech/mercks-hiv-combo-matches-gileads-biktarvy-phase-3-test" hreflang="en">Merck's HIV combo matches Gilead's Biktarvy in latest phase 3 test for islatravir</a>](https://www.fiercebiotech.com/biotech/mercks-hiv-combo-matches-gileads-biktarvy-phase-3-test)**  
  _Nov 19, 2025 8:14am_  
  Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease.

- **[<a href="https://www.fiercebiotech.com/biotech/gilead-wants-us-rebuild-why-galapagos-cant-go-extinct-despite-turbulent-year" hreflang="en">'Gilead wants us to rebuild': Why Galapagos isn't allowed to go extinct after turbulent year</a>](https://www.fiercebiotech.com/biotech/gilead-wants-us-rebuild-why-galapagos-cant-go-extinct-despite-turbulent-year)**  
  _Nov 19, 2025 6:56am_  
  CEO Paul Stoffels has left, and his cell therapy strategy has been scrapped. So what happened to Galapagos?

- **[<a href="https://www.fiercebiotech.com/biotech/top-our-game-lilly-picks-philadelphia-next-spot-early-stage-biotech-lab-space" hreflang="en">'At the top of our game': Lilly picks Philadelphia as next spot for early-stage biotech lab space</a>](https://www.fiercebiotech.com/biotech/top-our-game-lilly-picks-philadelphia-next-spot-early-stage-biotech-lab-space)**  
  _Nov 18, 2025 4:47pm_  
  As the biopharma world predominantly zeroes in on late-stage assets, Eli Lilly is prioritizing early science with the opening of a new Gateway Labs site, this time in Philadelphia.

- **[<a href="https://www.fiercebiotech.com/biotech/gsk-pens-50m-ltz-pact-join-big-pharma-peers-emerging-modality" hreflang="en">GSK pens $50M LTZ pact to join Big Pharma peers in emerging myeloid cell engager space</a>](https://www.fiercebiotech.com/biotech/gsk-pens-50m-ltz-pact-join-big-pharma-peers-emerging-modality)**  
  _Nov 19, 2025 4:41am_  
  GSK has paid $50 million upfront to partner with LTZ Therapeutics on myeloid cell engagers, expanding its cancer pipeline to cover a modality that has attracted Eli Lilly, Novartis, Pfizer and Sanofi.

- **[<a href="https://www.fiercebiotech.com/medtech/cardiac-tech-pushes-medtronics-quarterly-earnings-past-expectations" hreflang="en">Cardiac tech pushes Medtronic's quarterly earnings past expectations</a>](https://www.fiercebiotech.com/medtech/cardiac-tech-pushes-medtronics-quarterly-earnings-past-expectations)**  
  _Nov 18, 2025 10:38am_  
  The medtech giantâ€™s CEO, Geoff Martha, described the moment as a pivotal inflection point for the company.

- **[<a href="https://www.fiercebiotech.com/biotech/vanda-tackles-wegovy-driven-vomiting-sparking-race-phase-3" hreflang="en">Vanda tackles Wegovy-driven vomiting, sparking race to phase 3</a>](https://www.fiercebiotech.com/biotech/vanda-tackles-wegovy-driven-vomiting-sparking-race-phase-3)**  
  _Nov 18, 2025 10:19am_  
  Vanda Pharmaceuticalsâ€™ expansion into the booming GLP-1 market has cleared a midphase test. With the trial linking tradipitant to reduced nausea and vomiting in Wegovy patients, the biotech is gearing up to start a phase 3 trial in the setting in the first half of next year.

- **[<a href="https://www.fiercebiotech.com/biotech/jefferies-london-conference-cements-reputation-jp-morgan-europe" hreflang="en">Jefferies' London conference cements reputation as 'JP Morgan for Europe'</a>](https://www.fiercebiotech.com/biotech/jefferies-london-conference-cements-reputation-jp-morgan-europe)**  
  _Nov 18, 2025 9:02am_  
  This year saw attendance jump again, with an estimated 4,500 people from 50 countries and across 950 healthcare companies set to show up.

- **[<a href="https://www.fiercebiotech.com/medtech/cornerstone-robotics-secures-200m-funds-support-robotic-surgery" hreflang="en">Cornerstone Robotics secures $200M to build out its surgical system's global reach</a>](https://www.fiercebiotech.com/medtech/cornerstone-robotics-secures-200m-funds-support-robotic-surgery)**  
  _Nov 18, 2025 8:14am_  
  Cornerstone Robotics has raised about $200 million to help the Hong Kong company expand the global reach of its surgical platform.

- **[<a href="https://www.fiercebiotech.com/biotech/roches-oral-serd-goes-2-2-hitting-goal-phase-3-adjuvant-breast-cancer-trial" hreflang="en">Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial</a>](https://www.fiercebiotech.com/biotech/roches-oral-serd-goes-2-2-hitting-goal-phase-3-adjuvant-breast-cancer-trial)**  
  _Nov 18, 2025 8:39am_  
  Roche has reported another phase 3 win for its oral selective estrogen receptor degrader. Success at a planned interim analysis positions giredestrant for use in the adjuvant setting, setting the Swiss drugmaker up to target a currently unoccupied niche of a competitive market.

- **[<a href="https://www.fiercebiotech.com/biotech/how-biogen-returning-its-roots-west-coast-immunology-outpost" hreflang="en">How Biogen is returning to its roots with a West Coast immunology outpost</a>](https://www.fiercebiotech.com/biotech/how-biogen-returning-its-roots-west-coast-immunology-outpost)**  
  _Nov 18, 2025 10:46am_  
  On its face, there wasnâ€™t much notable about Biogenâ€™s May 2024 acquisition of Human Immunology Biosciences (HI-Bio). A $1.15 billion upfront payment to secure a phase 3-ready monoclonal antibody is chump change in the broader world of biopharma M&A, the kind of deal companies strike every day in this industry.


## Regeneron Press Releases

- **[LibtayoÂ® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with High Risk of Recurrence after Surgery and Radiation](https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-european-union-first-and-only)**  
  _Wed, 19 Nov 2025 07:00:00 -0500_  
  Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free survival in CSCC in the adjuvant setting, reducing the risk of recurrence or death by 68% (hazard ratio: 0.32; 95% confidence interval: 0.20-0.51; p0.0001)


## arXiv q-bio

- **[Subject-Independent Imagined Speech Detection via Cross-Subject Generalization and Calibration](https://arxiv.org/abs/2511.13739)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13739v1 Announce Type: new 
Abstract: Achieving robust generalization across individuals remains a major challenge in electroencephalogram based imagined speech decoding due to substantial variability in neural activity patterns. This study examined how training dynamics and lightweight subject specific adaâ€¦

- **[CellStream: Dynamical Optimal Transport Informed Embeddings for Reconstructing Cellular Trajectories from Snapshots Data](https://arxiv.org/abs/2511.13786)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13786v1 Announce Type: new 
Abstract: Single-cell RNA sequencing (scRNA-seq), especially temporally resolved datasets, enables genome-wide profiling of gene expression dynamics at single-cell resolution across discrete time points. However, current technologies provide only sparse, static snapshots of cellâ€¦

- **[GeoPl@ntNet: A Platform for Exploring Essential Biodiversity Variables](https://arxiv.org/abs/2511.13790)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13790v1 Announce Type: new 
Abstract: This paper describes GeoPl@ntNet, an interactive web application designed to make Essential Biodiversity Variables accessible and understandable to everyone through dynamic maps and fact sheets. Its core purpose is to allow users to explore high-resolution AI-generatedâ€¦

- **[XAI-Driven Deep Learning for Protein Sequence Functional Group Classification](https://arxiv.org/abs/2511.13791)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13791v1 Announce Type: new 
Abstract: Proteins perform essential biological functions, and accurate classification of their sequences is critical for understanding structure-function relationships, enzyme mechanisms, and molecular interactions. This study presents a deep learning-based framework for functioâ€¦

- **[MAT-MPNN: A Mobility-Aware Transformer-MPNN Model for Dynamic Spatiotemporal Prediction of HIV Diagnoses in California, Florida, and New England](https://arxiv.org/abs/2511.13797)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13797v1 Announce Type: new 
Abstract: Human Immunodeficiency Virus (HIV) has posed a major global health challenge for decades, and forecasting HIV diagnoses continues to be a critical area of research. However, capturing the complex spatial and temporal dependencies of HIV transmission remains challenging.â€¦

- **[Symbiotic causal network of seagrass-bacteria-alga-diatom interactions](https://arxiv.org/abs/2511.13799)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13799v1 Announce Type: new 
Abstract: Seagrass meadows contribute to the conservation of marine ecosystems, reduction in global warming impacts and pathogen controls. However, the decline in seagrass habitats due to environmental loads has become an urgent global issue. One way to address this issue is to bâ€¦

- **[A Disentangled Low-Rank RNN Framework for Uncovering Neural Connectivity and Dynamics](https://arxiv.org/abs/2511.13899)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13899v1 Announce Type: new 
Abstract: Low-rank recurrent neural networks (lrRNNs) are a class of models that uncover low-dimensional latent dynamics underlying neural population activity. Although their functional connectivity is low-rank, it lacks disentanglement interpretations, making it difficult to assâ€¦

- **[Stoichiometric ontogenetic development influences population dynamics: Stage-structured model under nutrient co-limitations](https://arxiv.org/abs/2511.13901)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13901v1 Announce Type: new 
Abstract: Ecological processes depend on the flow and balance of essential elements such as carbon (C) and phosphorus (P), and changes in these elements can cause adverse effects to ecosystems. The theory of Ecological Stoichiometry offers a conceptual framework to investigate thâ€¦

- **[Structural Flexibility of the TCF7L2-DNA Complex with the Type 2 Diabetes SNP rs7903146](https://arxiv.org/abs/2511.13916)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13916v1 Announce Type: new 
Abstract: The single nucleotide polymorphism (SNP) rs7903146 in the TCF7L2 gene has been determined as one of the strongest common genetic risk factors for Type 2 Diabetes (T2D). The location of the SNP in a non-coding region suggests a regulatory mechanism, meaning the SNP doesnâ€¦

- **[A Brain Wave Encodes a Thousand Tokens: Modeling Inter-Cortical Neural Interactions for Effective EEG-based Emotion Recognition](https://arxiv.org/abs/2511.13954)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13954v1 Announce Type: new 
Abstract: Human emotions are difficult to convey through words and are often abstracted in the process; however, electroencephalogram (EEG) signals can offer a more direct lens into emotional brain activity. Recent studies show that deep learning models can process these signalsâ€¦

- **[Classification of Aortic Shape with Topographical Pair Correlation Functions](https://arxiv.org/abs/2511.13960)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13960v1 Announce Type: new 
Abstract: Quantitative descriptors convert high-dimensional medical images into low-dimensional features capable of differentiating organ shapes that correlate with injury or disease progression for diagnostic purposes. An important example is aortic dissections, which can be imaâ€¦

- **[Evolutionary Hysteresis: Cycling about in a Rugged Landscape](https://arxiv.org/abs/2511.14090)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14090v1 Announce Type: new 
Abstract: In this work, we integrate theoretical modeling, molecular simulation, and empirical analysis to identify and characterize evolutionary hysteresis. We first show how epistatic interactions create bistable fitness landscapes and structural hysteresis in a two-locus Wrighâ€¦

- **[A region-specific brain dysfunction underlies cognitive impairment in long COVID brain fog](https://arxiv.org/abs/2511.14188)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14188v1 Announce Type: new 
Abstract: Long COVID "brain fog" is a common and debilitating subjective syndrome often associated with persistent cognitive impairment after COVID-19 infection. Here we identify a specific regional brain dysfunction that mediates this cognitive impairment and provide evidence thâ€¦

- **[BiRNe: Symbolic bifurcation analysis of reaction networks with Python](https://arxiv.org/abs/2511.14431)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14431v1 Announce Type: new 
Abstract: Computer algebra methods for analyzing reaction networks often rely on the assumption of mass-action kinetics, which transform the governing ODEs into polynomial systems amenable to techniques such as Gr\"obner basis computation and related algebraic tools. However, theâ€¦

- **[Multi-network Topology Underlying Individual Language Learning Success](https://arxiv.org/abs/2511.14453)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14453v1 Announce Type: new 
Abstract: Adult language learning varies greatly among individuals. Traditionally associated with frontotemporal language regions, this variability is increasingly seen as stemming from distributed brain networks. However, the role of these networks and their topological organizaâ€¦

- **[DecNefLab: A Modular and Interpretable Simulation Framework for Decoded Neurofeedback](https://arxiv.org/abs/2511.14555)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14555v1 Announce Type: new 
Abstract: Decoded Neurofeedback (DecNef) is a flourishing non-invasive approach to brain modulation with wide-ranging applications in neuromedicine and cognitive neuroscience. However, progress in DecNef research remains constrained by subject-dependent learning variability, reliâ€¦

- **[Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models](https://arxiv.org/abs/2511.14559)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14559v1 Announce Type: new 
Abstract: Deep generative models are rapidly advancing structure-based drug design, offering substantial promise for generating small molecule ligands that bind to specific protein targets. However, most current approaches assume a rigid protein binding pocket, neglecting the intâ€¦

- **[ApexGen: Simultaneous design of peptide binder sequence and structure for target proteins](https://arxiv.org/abs/2511.14663)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14663v1 Announce Type: new 
Abstract: Peptide-based drugs can bind to protein interaction sites that small molecules often cannot, and are easier to produce than large protein drugs. However, designing effective peptide binders is difficult. A typical peptide has an enormous number of possible sequences, anâ€¦

- **[Hyperbolic Graph Embeddings Reveal the Host-Pathogen Interactome](https://arxiv.org/abs/2511.14669)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14669v1 Announce Type: new 
Abstract: Infections depend on interactions between pathogen and host proteins, but comprehensively mapping these interactions is challenging and labor intensive. Many biological networks have hierarchical, scale-free structure, so we developed a deep learning framework, ApexPPI,â€¦

- **[Exploring AlphaFold 3 for CD47 Antibody-Antigen Binding Affinity: An Unexpected Discovery of Reverse docking](https://arxiv.org/abs/2511.14676)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14676v1 Announce Type: new 
Abstract: AlphaFold 3 (AF3) is a powerful biomolecular structure-predicting tool based on the latest deep learning algorithms and revolutionized AI model architectures. A few of papers have already investigated its accuracy in predicting different biomolecular structures. Howeverâ€¦

- **[Near-Lossless Model Compression Enables Longer Context Inference in DNA Large Language Models](https://arxiv.org/abs/2511.14694)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14694v1 Announce Type: new 
Abstract: Trained on massive cross-species DNA corpora, DNA large language models (LLMs) learn the fundamental "grammar" and evolutionary patterns of genomic sequences. This makes them powerful priors for DNA sequence modeling, particularly over long ranges. However, two major coâ€¦

- **[THD-BAR: Topology Hierarchical Derived Brain Autoregressive Modeling for EEG Generic Representations](https://arxiv.org/abs/2511.13733)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13733v1 Announce Type: cross 
Abstract: Large-scale pre-trained models hold significant potential for learning universal EEG representations. However, most existing methods, particularly autoregressive (AR) frameworks, primarily rely on straightforward temporal sequencing of multi-channel EEG data, which faâ€¦

- **[Gene Incremental Learning for Single-Cell Transcriptomics](https://arxiv.org/abs/2511.13762)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.13762v1 Announce Type: cross 
Abstract: Classes, as fundamental elements of Computer Vision, have been extensively studied within incremental learning frameworks. In contrast, tokens, which play essential roles in many research fields, exhibit similar characteristics of growth, yet investigations into theirâ€¦

- **[Integral Bayesian symbolic regression for optimal discovery of governing equations from scarce and noisy data](https://arxiv.org/abs/2511.14388)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2511.14388v1 Announce Type: cross 
Abstract: Understanding how systems evolve over time often requires discovering the differential equations that govern their behavior. Automatically learning these equations from experimental data is challenging when the data are noisy or limited, and existing approaches struggâ€¦

- **[Benchmark on Drug Target Interaction Modeling from a Drug Structure Perspective](https://arxiv.org/abs/2407.04055)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2407.04055v2 Announce Type: replace 
Abstract: The prediction modeling of drug-target interactions is crucial to drug discovery and design, which has seen rapid advancements owing to deep learning technologies. Recently developed methods, such as those based on graph neural networks (GNNs) and Transformers, demoâ€¦

- **[Quantum Models of Consciousness from a Quantum Information Science Perspective](https://arxiv.org/abs/2501.03241)**  
  _Wed, 19 Nov 2025 00:00:00 -0500_  
  arXiv:2501.03241v3 Announce Type: replace 
Abstract: This perspective explores various quantum models of consciousness from the viewpoint of quantum information science, offering potential ideas and insights. The models under consideration can be categorized into three distinct groups based on the level at which quantâ€¦
